Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Micropump® is a controlled release and taste-masking technology for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for the development of Coreg CR®. Flamel’s Medusa® technology is designed to deliver controlled-release formulations of therapeutic proteins. ( www.flamel.com )
Flamel Technologies , S.A.
1825 K. Street Suite 1210
Washington, District of Columbia 20006
USA
Tel: (202) 862-8400
Fax: (202) 862-3933